COLD, FLU & COUGH NEWS AND RESEARCH
Latest Cold, Flu & Cough News and Research
Regeneron antibody cocktail shows promise as potential COVID-19 treatment
Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).
Study finds low rate of COVID-19 transmission in educational settings
The rate of COVID-19 transmission in New South Wales (NSW) educational settings was extremely limited during the first wave of COVID-19, research findings published today in The Lancet Child and Adolescent Health have shown.
Estrogen modestly protective against COVID-19?
Almost from the beginning, scientists have been struck by the disproportionately higher numbers of men and older adults who have developed severe COVID-19 disease compared to younger individuals and women. Prior research has shown that in 37 of the 38 countries from which sex-stratified data was available, males were at a higher risk of death. Also, post-menopausal women are at increased risk of severe COVID-19. However, the biological underpinnings of this have been less visible.
Extensive study of SARS-CoV-2 sequencing reveals six strains of the virus
The virus causing the COVID-19 pandemic, SARS-CoV-2, presents at least six strains. Despite its mutations, the virus shows little variability, and this is good news for the researchers working on a viable vaccine.
California GOP consultant rues ‘big mistake’ that led to family’s COVID infections
The tweet Richard Costigan posted July 23 was bluntly honest: "We tried our best to limit exposure to #COVID19 but we slipped up somewhere."
Novel short ACE2 isoform may influence SARS-CoV-2 susceptibility
A study led by researchers at the University of Southampton, UK, has identified a novel short isoform of the full-length receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain entry to host cells.
Oxford University and ZOE join forces to widen access to COVID-19 treatment trials
Oxford University and the COVID Symptom Study app are joining forces to widen access to two clinical trials of potential treatments for COVID-19.
Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test
Oxford Nanopore today announces an agreement with the UK’s Department of Health and Social Care, to roll out its novel LamPORE test.
Maternal vaccination could protect infants against RSV illness
Immunizing pregnant women with a potential vaccine against RSV could prevent the most common cause of pneumonia in their babies.
Immune system's oldest branches may underpin COVID severity
One of the immune system's oldest branches, called complement, may be influencing the severity of COVID disease, according to a new study from researchers at Columbia University Irving Medical Center.
What seniors can expect as their new normal in a post-vaccine world
Imagine this scenario, perhaps a year or two in the future: An effective COVID-19 vaccine is routinely available and the world is moving forward. Life, however, will likely never be the same — particularly for people over 60.
_8421a59ab9e8408b98d536115c6b538f-150x125.jpg "Pre-COVID-19 coronavirus antibodies fail to neutralize SARS-CoV-2")
Pre-COVID-19 coronavirus antibodies fail to neutralize SARS-CoV-2
Researchers in Austria have shown that antibodies with potent neutralizing activity against a well-established seasonal coronavirus had no neutralizing activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
_119063aa626d4bbfbbebcfa8638a9ec9-150x125.jpg "Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19")
Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19
Now, a new study published on the preprint server medRxiv in July 2020 reports that an older treatment modality, namely, the use of convalescent antibody-rich plasma, brings down the mortality rate in hospitalized COVID-19 patients by an astonishing 57%. This adds evidence for the use of convalescent plasma in the treatment of high-risk patients.
_fd43ab24ac3f4c9d84fa35718ae847c7-150x125.jpg "Children carry 100 times more SARS-CoV-2 virus as adults, study says")
Children carry 100 times more SARS-CoV-2 virus as adults, study says
As the coronavirus disease (COVID-19) continues to wreak havoc across the globe, it has been thought that children mostly seemed to be spared by severe illness. In the majority of cases, children infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only develop a mild illness, with some tagged as asymptomatic.
Avoiding care during the pandemic could mean life or death
These days, Los Angeles acting teacher Deryn Warren balances her pain with her fear. She's a bladder cancer patient who broke her wrist in November. She still needs physical therapy for her wrist, and she's months late for a cancer follow-up.
New article reviews poor life expectancy associated with treatment-resistant schizophrenia
The vast majority of reviews on psychotropic drugs is focused on the potential benefits that may have. However, the vulnerabilities induced by treatment need also to be considered.
New simple way of detecting COVID-19 in blood plasma
Even as the COVID-19 pandemic claims increasing numbers of patients, testing numbers are rising in most nations at the leading edge. However, the current reverse transcriptase-polymerase chain reaction (RT PCR) testing is often unavailable and takes up to several days for results to arrive.
Researchers report a liquid biopsy for COVID-19
A new study published on the preprint server medRxiv in July 2020 reports the potential of cell-free DNA as a marker of the severity of disease in COVID-19. This could help triage patients as well as provide a prognostic marker.
_e9346fd2cd384e60a7efc560bb99900b-150x125.jpg "From swab to sequencing - scalable method for identifying SARS-CoV-2")
From swab to sequencing - scalable method for identifying SARS-CoV-2
A research group headed by Stanford University scientists has developed a scalable, high throughput method to generate high fidelity whole genome and HLA sequencing, viral genomes, and representation of human transcriptome from single nasopharyngeal swabs of coronavirus disease (COVID19) patients. Their results are published on the medRxiv preprint server.
Deep neural networks to identify pneumonia caused by COVID-19 in CT scans
As COVID-19 cases in the United States continue to surge, there is an ongoing search for quick and reliable testing.
No hay comentarios:
Publicar un comentario